BR0312026A - Microcápsulas para a liberação retardada e controlada do perindopril - Google Patents

Microcápsulas para a liberação retardada e controlada do perindopril

Info

Publication number
BR0312026A
BR0312026A BR0312026-0A BR0312026A BR0312026A BR 0312026 A BR0312026 A BR 0312026A BR 0312026 A BR0312026 A BR 0312026A BR 0312026 A BR0312026 A BR 0312026A
Authority
BR
Brazil
Prior art keywords
perindopril
delayed
microcapsules
controlled release
release
Prior art date
Application number
BR0312026-0A
Other languages
English (en)
Inventor
Bruno Huet De Barochez
Patrick Wuthrich
Valerie Legrand
Catherine Castan
Remi Meyrueix
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BR0312026A publication Critical patent/BR0312026A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

"MICROCáPSULAS PARA A LIBERAçãO RETARDADA E CONTROLADA DO PERINDOPRIL". A presente invenção refere-se às microcápsulas, permitindo a liberação retardada e controlada de perindopril, ou de um de seus sais farmaceuticamente aceitáveis, destinados a uma administração por via oral.
BR0312026-0A 2002-06-24 2003-06-24 Microcápsulas para a liberação retardada e controlada do perindopril BR0312026A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0207778A FR2841140B1 (fr) 2002-06-24 2002-06-24 Microcapsules pour la liberation retardee et controlee du perindopril
PCT/FR2003/001931 WO2004000286A1 (fr) 2002-06-24 2003-06-24 Microcapsules pour la liberation retardee et controlee du perindopril

Publications (1)

Publication Number Publication Date
BR0312026A true BR0312026A (pt) 2005-03-22

Family

ID=29719985

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312026-0A BR0312026A (pt) 2002-06-24 2003-06-24 Microcápsulas para a liberação retardada e controlada do perindopril

Country Status (37)

Country Link
US (1) US20060165808A1 (pt)
EP (1) EP1515704B1 (pt)
JP (1) JP4723243B2 (pt)
KR (1) KR100722082B1 (pt)
CN (1) CN100345541C (pt)
AP (1) AP2029A (pt)
AR (1) AR040461A1 (pt)
AT (1) ATE429214T1 (pt)
AU (1) AU2003260620B2 (pt)
BR (1) BR0312026A (pt)
CA (1) CA2491172C (pt)
CR (1) CR7648A (pt)
CY (1) CY1109154T1 (pt)
DE (1) DE60327318D1 (pt)
DK (1) DK1515704T3 (pt)
EA (1) EA007571B1 (pt)
EC (1) ECSP055570A (pt)
ES (1) ES2326218T3 (pt)
FR (1) FR2841140B1 (pt)
GE (1) GEP20074212B (pt)
HR (1) HRP20050055B1 (pt)
IL (1) IL165896A0 (pt)
IS (1) IS2679B (pt)
MA (1) MA27262A1 (pt)
ME (1) ME00452B (pt)
MX (1) MXPA05000086A (pt)
NO (1) NO20050163L (pt)
NZ (1) NZ537408A (pt)
OA (1) OA12875A (pt)
PL (1) PL374377A1 (pt)
PT (1) PT1515704E (pt)
RS (1) RS50914B (pt)
SI (1) SI1515704T1 (pt)
TN (1) TNSN04259A1 (pt)
UA (1) UA81121C2 (pt)
WO (1) WO2004000286A1 (pt)
ZA (1) ZA200410333B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
BRPI0615607A2 (pt) * 2005-08-30 2011-05-24 Lek Pharmaceuticals composição farmacêutica compreendendo perindopril ou seus sais
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FI125776B2 (fi) 2008-06-27 2023-07-28 Metsaeliitto Osuuskunta Menetelmä puulevyn käsittelemiseksi
CN106983731A (zh) * 2017-04-20 2017-07-28 上药东英（江苏）药业有限公司 一种培哚普利控释片及其制备方法
DE102018123500A1 (de) 2018-09-25 2020-03-26 Man Energy Solutions Se Vorrichtung und Verfahren zur Einstellung der Länge einer Pleuelstange eines Zylinders einer Brennkraftmaschine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2247186A1 (de) * 1972-09-26 1974-03-28 Bayer Ag Antimykotisches mittel
JPS55129219A (en) * 1979-03-29 1980-10-06 Asahi Chem Ind Co Ltd Slow-releasing preparation
EP1442745A1 (en) * 1993-10-07 2004-08-04 Euro-Celtique Orally administrable opioid formulations having extended duration of effect
DE19724696A1 (de) 1997-06-12 1998-12-24 Hexal Ag Pharmazeutische Zubereitung mit drei Pelletarten
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
JPH11171769A (ja) * 1997-12-05 1999-06-29 Nichiko Pharmaceutical Co Ltd ３−イソブチリル−２−イソプロピルピラゾロ〔１，５−ａ〕ピリジンの徐放性製剤及びその製法
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
CA2409437A1 (en) * 2000-05-11 2001-11-22 Pharmacia Corporation Aldosterone antagonist composition for release during aldosterone acrophase
IL164222A0 (en) * 2002-04-09 2005-12-18 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
CN1189150C (zh) * 2002-11-07 2005-02-16 张凤英 祛斑美白面膜
CN100389300C (zh) * 2004-01-17 2008-05-21 湖北清江水布垭工程建设公司 大坝面板挠度或坝体内部变形监测方法及装置

Also Published As

Publication number Publication date
FR2841140B1 (fr) 2004-10-01
IL165896A0 (en) 2006-01-15
NO20050163L (no) 2005-01-12
AU2003260620B2 (en) 2008-07-31
RS50914B (sr) 2010-08-31
MXPA05000086A (es) 2005-04-08
PT1515704E (pt) 2009-05-20
EA007571B1 (ru) 2006-12-29
EA200500030A1 (ru) 2005-06-30
AU2003260620A1 (en) 2004-01-06
KR100722082B1 (ko) 2007-05-25
ECSP055570A (es) 2006-04-19
US20060165808A1 (en) 2006-07-27
CY1109154T1 (el) 2014-07-02
DE60327318D1 (de) 2009-06-04
JP2005533079A (ja) 2005-11-04
ZA200410333B (en) 2006-07-26
CR7648A (es) 2005-07-18
ME00452B (me) 2011-10-10
CN1665491A (zh) 2005-09-07
JP4723243B2 (ja) 2011-07-13
ATE429214T1 (de) 2009-05-15
AP2029A (en) 2009-08-24
TNSN04259A1 (fr) 2007-03-12
CA2491172A1 (fr) 2003-12-31
HRP20050055B1 (hr) 2013-11-08
IS7634A (is) 2005-01-07
EP1515704B1 (fr) 2009-04-22
DK1515704T3 (da) 2009-07-20
SI1515704T1 (sl) 2009-08-31
MA27262A1 (fr) 2005-03-01
UA81121C2 (en) 2007-12-10
RS112904A (en) 2007-02-05
EP1515704A1 (fr) 2005-03-23
CA2491172C (fr) 2011-02-15
AR040461A1 (es) 2005-04-06
PL374377A1 (en) 2005-10-17
NZ537408A (en) 2006-07-28
ES2326218T3 (es) 2009-10-05
AP2004003193A0 (en) 2004-12-31
OA12875A (en) 2006-09-15
KR20050023337A (ko) 2005-03-09
HRP20050055A2 (en) 2005-02-28
WO2004000286A1 (fr) 2003-12-31
FR2841140A1 (fr) 2003-12-26
CN100345541C (zh) 2007-10-31
IS2679B (is) 2010-09-15
GEP20074212B (en) 2007-10-10

Similar Documents

Publication Publication Date Title
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
HUP0203204A2 (hu) Orális adagolási forma
EG25542A (en) Oral dosge forms for propiverne or pharmaceutically acceptable salts thereof having prolonged release of the active agent
NO20052479L (no) Tramadolformuleringer med forsinket frigjoring og 24 timers effektivitet
BRPI0518266B8 (pt) medicamento oral de liberação modificada de pelo menos um princípio ativo sob a forma multimicrocapsular
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
BR0317600A (pt) ácidos heteroarilalcanóicos como derivados de antagonistas de receptor de integrina
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
BRPI0407097A (pt) Antagonista do casr
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
NO20013060L (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
BRPI0413013A (pt) composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças
NO20064808L (no) Orale matrixformuleringer med licarbazepin
NO20045385L (no) Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff
BR0113590A (pt) 7-oxo-piridopirimidinas
BR0013793A (pt) Medicamentos profiláticos e terapêuticos para doenças oftálmicas
HRP20050075A2 (en) Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
CY1109154T1 (el) Μικροκαψουλες για την καθυστερημενη και ελεγχομενη απελευθερωση της περινδοπριλης
BR0116060A (pt) Composição farmacêutica de dronedarona para administração parenteral
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
BR0307048A (pt) Composição farmacêutica orodispersìvel de perindoprila
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
BR0210327A (pt) Microcápsulas para proteção do hálito

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA:INT.CI. A61K 9/50, A61K 31/40, A61K 31/401, A61K 38/55, A61P 43/00, A61P 9/00, A61P 9/04, A61P 9/12

Ipc: A61K 9/50 (2011.01), A61K 31/40 (2011.01), A61K 31

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]